Genexine, a Korean biopharmaceutical company, has merged with EPD Biotherapeutics, specializing in targeted protein degradation (TPD) technology. This merger...

Calidi Biotherapeutics has authorized a one-for-ten reverse stock split, effective July 15, 2024. The split will be applied to...

ACTICOR BIOTECH, a clinical-stage pharmaceutical company, reports its voting rights and shares as of May 31, 2024. The company...

At the recent Clinical Trial Outsourcing East Coast conference, Rachel Nering, Global Head of Early Development Clinical Operations at...

Merck and Orion Corporation have converted their co-development and co-commercialization agreement for opevesostat into an exclusive global license for...

N-Power Medicine has secured initial funding in a Series B round, boosting its total funding to $72 million. Led...

TauRx Pharmaceuticals has submitted a Marketing Authorisation Application (MAA) in the UK for hydromethylthionine mesylate (HMTM), a potential treatment...

Mendel, a leader in clinical AI, has announced advancements in its neuro-Symbolic AI system, which automates the identification of...

Integrating AI is a game-changer in the ever-evolving landscape of clinical trials, and it is now being applied to...

The clinical trial industry is experiencing a significant shift in investment capital, with a current focus on innovative technology...